Cancers (Jan 2023)
Correction: Zheng et al. Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy. <i>Cancers</i> 2022, <i>14</i>, 5344
Abstract
The authors wish to make the following corrections to this paper [...]
Keywords